AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,726,026 | -19.7% | 479,540 | 0.0% | 0.10% | -9.1% |
| Q2 2023 | $4,641,947 | -11.7% | 479,540 | 0.0% | 0.11% | -12.0% |
| Q1 2023 | $5,255,758 | +153.7% | 479,540 | 0.0% | 0.12% | +150.0% |
| Q4 2022 | $2,071,613 | -74.2% | 479,540 | -55.0% | 0.05% | -75.8% |
| Q3 2022 | $8,019,000 | -2.1% | 1,066,408 | +30.8% | 0.21% | -13.0% |
| Q2 2022 | $8,192,000 | -14.2% | 815,126 | +5.7% | 0.24% | -0.8% |
| Q1 2022 | $9,545,000 | -8.7% | 771,018 | +68.6% | 0.24% | -0.8% |
| Q4 2021 | $10,456,000 | -23.0% | 457,173 | -25.5% | 0.24% | -15.1% |
| Q3 2021 | $13,572,000 | +33.3% | 613,269 | -22.0% | 0.28% | +41.8% |
| Q2 2021 | $10,184,000 | +0.3% | 785,769 | +0.5% | 0.20% | -9.0% |
| Q1 2021 | $10,149,000 | -5.1% | 781,569 | +1.0% | 0.22% | -2.6% |
| Q4 2020 | $10,700,000 | -6.0% | 773,669 | +0.1% | 0.23% | -21.5% |
| Q3 2020 | $11,380,000 | – | 772,569 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 111,608 | $2,470,000 | 3.15% |
| ACT CAPITAL MANAGEMENT, LLC | 180,000 | $3,983,000 | 2.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 167,889 | $3,715,000 | 1.92% |
| DG Capital Management, LLC | 402,200 | $8,901,000 | 1.81% |
| NEA Management Company, LLC | 5,172,683 | $114,471,000 | 1.36% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 801,100 | $17,728,000 | 0.99% |
| Altium Capital Management LP | 144,000 | $3,187,000 | 0.84% |
| HighMark Wealth Management LLC | 50,569 | $1,119,000 | 0.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 123,500 | $2,724,000 | 0.66% |
| SEVEN EIGHT CAPITAL, LP | 288,840 | $6,392,000 | 0.62% |